Size dependence of nanoparticle-protein interaction and high sensitivity potentiometric sensor exploiting such interactions

US10370694B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10370694-B2
Application numberUS-201615156648-A
CountryUS
Kind codeB2
Filing dateMay 17, 2016
Priority dateMay 19, 2015
Publication dateAug 6, 2019
Grant dateAug 6, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Fabrication of a high sensitivity potentiometric biosensor is described. The present inventors have developed and characterized a novel amplification platform using a gold nanoparticle (GNPs) electrodeposition method. The synthesized GNP sizes were found to be dependent of HAuCl4 concentration, media acid, scan cycles and scan rate. A systematic investigation into the adsorption of different sizes of proteins from aqueous electrolyte solution onto the electrodeposited GNPs surface by the potentiometric method was performed. Results suggest that the size of different proteins affect how they bond to different sizes of GNPs. This GNPs-based biosensor can retain the native-like structure of proteins, and successfully detect proteins at a high sensitivity level. The resulting glucose and immune biosensors also exhibit low detection limit and wide linear range. This improvement to potentiometric devices enables them to serve as highly sensitive detectors for biomolecules and provides a model that can be used to predict protein bonding on nanoparticles.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for making a potentiometric biosensor including a specific protein adsorbed onto gold nanoparticles, the method comprising: a) electrodepositing gold onto an electrode to produce a gold nanoparticle modified electrode, wherein the electrodepositing uses electrodeposition parameters selected to deposit gold nanoparticles on the electrode such that a mean size of the deposited gold nanoparticles corresponds to a size promoting, relative to other mean sizes of deposited gold nanoparticles produced by other combinations of electrodeposition parameters, adsorption of the specific protein onto the gold nanoparticles; and b) adsorbing the specific protein onto the gold nanoparticle electrode to produce the potentiometric biosensor, wherein the specific protein selected from a group consisting of (A) Bovine serum albumin (BSA), (B) glucose oxidase (GOx), and (C) Casein, and wherein if the specific protein is BSA, then the mean size of the deposited gold nanoparticles is 5 nm±2 nm, if the specific protein is GOx, then the mean size of the deposited gold nanoparticles is 14 nm±2 nm, and if the specific protein is Casein, then the mean size of the deposited gold nanoparticles is 40 nm±2 nm. 2. The method of claim 1 wherein the act of electrodepositing is performed using cyclic voltemmetry electrodeposition. 3. The method of claim 2 wherein at least one of the electrodepostion parameters is a voltage scan rate. 4. The method of claim 2 wherein at least one of the electrodepostion parameters is a maximum number of scan cycles. 5. The method of claim 1 wherein the electrodepositing uses electrodeposition parameters selected to deposit gold nanoparticles on the electrode such that a mean size of the deposited gold nanoparticles corresponds to a size optimizing, relative to other mean sizes of deposited gold nanoparticles produced by other combinations of electrodeposition parameters, adsorption of the specific protein onto the gold nanoparticles. 6. A method for making a potentiometric biosensor including a specific protein adsorbed onto gold nanoparticles, the method comprising: a) electrodepositing gold onto an electrode to produce a gold nanoparticle modified electrode, wherein the electrodepositing uses electrodeposition parameters selected to deposit gold nanoparticles on the electrode such that a mean size of the deposited gold nanoparticles corresponds to a size promoting, relative to other mean sizes of deposited gold nanoparticles produced by other combinations of electrodeposition parameters, adsorption of the specific protein onto the gold nanoparticles; and b) adsorbing the specific protein onto the gold nanoparticle electrode to produce the potentiometric biosensor, wherein the act of electrodepositing is performed using cyclic voltemmetry electrodeposition, and wherein at least one of the electrodepostion parameters is acidic solution concentration. 7. A potentiometric biosensor comprising: a) an electrode; b) gold nanoparticles coating a surface of the electrode; and c) a specific protein adsorbed onto the gold nanoparticles, wherein a mean size of the gold nanoparticles is one that promoted, relative to other mean sizes of deposited gold nanoparticles produced by other combinations of electrodeposition parameters, the adsorption of the specific proteins, wherein the specific protein selected from a group consisting of (A) Bovine serum albumin (BSA), (B) glucose oxidase (GOx), and (C) Casein, and wherein if the specific protein is BSA, then the mean size of the deposited gold nanoparticles is 5 nm±2 nm, if the specific protein is GOx, then the mean size of the deposited gold nanoparticles is 14 nm±2 nm, and if the specific protein is Casein, then the mean size of the deposited gold nanoparticles is 40 nm±2 nm. 8. The potentiometric biosensor of claim 7 wherein the specific protein remains active after its adsorption onto the gold nanoparticles. 9. The potentiometric biosensor of claim 7 wherein the specific protein is not denatured by its adsorption onto the gold nanoparticles. 10. The potentiometric biosensor of claim 7 wherein a mean size of the gold nanoparticles is one that optimized, relative to other mean sizes of deposited gold nanoparticles produced by other combinations of electrodeposition parameters, the adsorption of the specific proteins.

Assignees

Inventors

Classifications

  • Electroplating of non-metallic surfaces (C25D7/12 takes precedence) · CPC title

  • Nanotechnology for materials or surface science, e.g. nanocomposites · CPC title

  • involving nanosized elements, e.g. nanogaps or nanoparticles (nanopores G01N33/48721; magnetic beads G01N27/745) · CPC title

  • Electroplating using modulated, pulsed or reversing current · CPC title

  • of gold · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10370694B2 cover?
Fabrication of a high sensitivity potentiometric biosensor is described. The present inventors have developed and characterized a novel amplification platform using a gold nanoparticle (GNPs) electrodeposition method. The synthesized GNP sizes were found to be dependent of HAuCl4 concentration, media acid, scan cycles and scan rate. A systematic investigation into the adsorption of different si…
Who is the assignee on this patent?
Univ New York
What technology area does this patent fall under?
Primary CPC classification C12Q1/006. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).